Research and Development Archives – Page 6 of 8

Statement on U.S. FDA Report Highlighting Gaps in Pediatric Research

August 27, 2019
Chad Cipiti

Treatment Action Group (TAG) welcomes a report released last week by the U.S. Food and Drug Administration (FDA) that highlights urgent gaps in pediatric research. This report confirms that we are missing critical information necessary to treat children affected by orphan diseases.

Story: HIV Eliminated from the Genomes of Living Animals

July 10, 2019
Dorrit Walsh

July 2019 Examples of media coverage: For the First Time, Researchers Eliminated HIV From the Genomes of Living Animals – TIME, July 2, 2019 Scientists eliminate HIV in the entire genome of lab mice for the first time ever: Breakthrough paves the…

Closing the Gap in Tuberculosis Research and Development Funding Briefs

February 20, 2019
Chad Cipiti

In our two briefs, Closing the Gap in Tuberculosis Research and Development Funding: Actions for U.S. Government Executive Agencies and Actions for U.S. Congress, we detail how a funding increase of 0.1 percent, based on "fair share" of research capacity, would close the funding gap in TB R&D, catalyze new public health tools we need to create positive health outcomes among communities vulnerable to TB worldwide.

A Pharma View on Delinkage and New Models for Biomedical Innovation: An Interview with Marc Destito from Otsuka Pharmaceutical

December 10, 2018
Chad Cipiti

by Mike Frick and Lindsay McKenna, TB Project Co-Directors, TAG In an interview with TAG’s Tuberculosis (TB) Project, Marc Destito, Senior Director of Public Affairs and Global Alliance Management at Otsuka Pharmaceutical, provides insight into how the development of TB…

Keeping an Eye on Intellectual Property Issues in HIV Cure and Prevention Research

December 10, 2018
Chad Cipiti

By Richard Jefferys, Basic Science, Vaccines, and Cure Project Director, TAG The history of antiretroviral (ARV) drug development offers many examples of compounds that were originally discovered and investigated by publicly funded academic researchers, before being acquired and ushered to…

Story: Claims that “Gammora” Represents a Potential HIV Cure

November 20, 2018
Dorrit Walsh

October – November 2018 Examples of media coverage: HIV cure? Major breakthrough made in eradicating deadly virus: ‘Beyond our expectations’ – Daily Star, November 1, 2018 New drug could cure HIV/Aids – Uganda Daily Monitor, November 7, 2018 Maker of ‘potential HIV…

Story: Cancer Drug Leads to ‘Drastic Decrease’ in HIV Infection in Lung Cancer Patient

December 10, 2017
Dorrit Walsh

November – December 2017 Examples of media coverage: Lung cancer drug may be early clue in hunt for HIV cure – The Independent, November 30, 2017 Cancer drug offers tantalising hope for HIV cure – The Guardian, November 30, 2017…

Higher Funding for TB Research Signals Hope, but Governments Must Dramatically Increase Spending to End TB

November 8, 2017
Chad Cipiti

Global funding for tuberculosis (TB) research reached a previously unreported high of $726 million in 2016, according to a report released today by Treatment Action Group (TAG) and the United Nations–hosted Stop TB Partnership.

Story: Nigerian Scientists Claim to Have Discovered Complete Cure for HIV/AIDS

February 10, 2017
Dorrit Walsh

December 2016 – February 2017, Updated May 2017 Examples of media coverage: Nigerian Scientists Claim To Have Discovered Complete Cure For HIV/AIDS – Nigerian Bulletin, December 13, 2016 Michael Okpara varsity discovers new cure of HIV/AIDS – Daily Trust, February…

Public Health Groups Welcome Johns Hopkins University and Medicines Patent Pool Agreement for Development of Promising New TB Drug

January 24, 2017
Chad Cipiti

Public health groups welcomed today’s announcement by Johns Hopkins University (JHU) and the Medicines Patent Pool (MPP) of an agreement that could expedite the research and development of a promising tuberculosis drug and lead to improved treatment options for people living with TB.